Works by Miller, Aaron E.

Results: 29

Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society.

Published in:

JAMA Neurology, 2021, v. 78, n. 2, p. 241, doi. 10.1001/jamaneurol.2020.4025

By:

Miller, Aaron E.;
Chitnis, Tanuja;
Cohen, Bruce A.;
Costello, Kathleen;
Sicotte, Nancy L.;
Stacom, Rachael

Publication type:

Article

Depression and cognitive function in early multiple sclerosis: Multitasking is more sensitive than traditional assessments.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 8, p. 1276, doi. 10.1177/1352458520958359

By:

Glukhovsky, Lisa;
Kurz, Daniel;
Brandstadter, Rachel;
Leavitt, Victoria M;
Krieger, Stephen;
Fabian, Michelle;
Katz Sand, Ilana;
Klineova, Sylvia;
Riley, Claire S;
Lublin, Fred D;
Miller, Aaron E;
Sumowski, James F

Publication type:

Article

Word-finding difficulty is a prevalent disease-related deficit in early multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1752, doi. 10.1177/1352458519881760

By:

Brandstadter, Rachel;
Fabian, Michelle;
Leavitt, Victoria M;
Krieger, Stephen;
Yeshokumar, Anusha;
Katz Sand, Ilana;
Klineova, Sylvia;
Riley, Claire S;
Lewis, Christina;
Pelle, Gabrielle;
Lublin, Fred D;
Miller, Aaron E;
Sumowski, James F

Publication type:

Article

Psychological resilience is linked to motor strength and gait endurance in early multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1111, doi. 10.1177/1352458519852725

By:

Klineova, Sylvia;
Brandstadter, Rachel;
Fabian, Michelle T;
Sand, Ilana Katz;
Krieger, Stephen;
Leavitt, Victoria M;
Lewis, Christina;
Riley, Claire S;
Lublin, Fred;
Miller, Aaron E;
Sumowski, James F

Publication type:

Article

Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials.

Published in:

Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1083, doi. 10.1177/1352458519851981

By:

Comi, Giancarlo;
Miller, Aaron E;
Benamor, Myriam;
Truffinet, Philippe;
Poole, Elizabeth M;
Freedman, Mark S

Publication type:

Article

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 535, doi. 10.1177/1352458517695468

By:

Freedman, Mark S.;
Wolinsky, Jerry S.;
Comi, Giancarlo;
Kappos, Ludwig;
Olsson, Tomas P.;
Miller, Aaron E.;
Thangavelu, Karthinathan;
Benamor, Myriam;
Truffinet, Philippe;
O’Connor, Paul W.

Publication type:

Article

Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy–Commentary.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 11, p. 1402, doi. 10.1177/1352458516649039

By:

Miller, Aaron E.

Publication type:

Article

Multiple sclerosis disease-modifying therapy and pregnancy.

Published in:

2016

By:

Miller, Aaron E.

Publication type:

Editorial

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2014, v. 20, n. 12, p. 1654, doi. 10.1177/1352458514521517

By:

Sand, Ilana Katz;
Krieger, Stephen;
Farrell, Colleen;
Miller, Aaron E

Publication type:

Article

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.

Published in:

Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 705, doi. 10.1177/1352458513507821

By:

Vermersch, Patrick;
Czlonkowska, Anna;
Grimaldi, Luigi ME;
Confavreux, Christian;
Comi, Giancarlo;
Kappos, Ludwig;
Olsson, Tomas P;
Benamor, Myriam;
Bauer, Deborah;
Truffinet, Philippe;
Church, Meg;
Miller, Aaron E;
Wolinsky, Jerry S;
Freedman, Mark S;
O’Connor, Paul

Publication type:

Article

Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis—performance improvement CME.

Published in:

Multiple Sclerosis Journal, 2014, v. 20, n. 1, p. 18, doi. 10.1177/1352458513495937

By:

Miller, Aaron E;
Cohen, Bruce A;
Krieger, Stephen C;
Markowitz, Clyde E;
Mattson, David H;
Tselentis, Helen N

Publication type:

Article

The best clinical paper on multiple sclerosis in 2012.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 520, doi. 10.1177/1352458513482386

By:

Miller, Aaron E

Publication type:

Article

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2012, v. 18, n. 11, p. 1625, doi. 10.1177/1352458512450354

By:

Miller, Aaron E;
O’Connor, Paul;
Wolinsky, Jerry S;
Confavreux, Christian;
Kappos, Ludwig;
Olsson, Tomas P;
Truffinet, Philippe;
Wang, Lin;
D’Castro, Laura;
Comi, Giancarlo;
Freedman, Mark S

Publication type:

Article

Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.

Published in:

Brain: A Journal of Neurology, 2014, v. 137, n. 8, p. 2271, doi. 10.1093/brain/awu139

By:

Vidaurre, Oscar G.;
Haines, Jeffery D.;
Katz Sand, Ilana;
Adula, Kadidia P.;
Huynh, Jimmy L.;
McGraw, Corey A.;
Zhang, Fan;
Varghese, Merina;
Sotirchos, Elias;
Bhargava, Pavan;
Bandaru, Veera Venkata Ratnam;
Pasinetti, Giulio;
Zhang, Weijia;
Inglese, Matilde;
Calabresi, Peter A.;
Wu, Gang;
Miller, Aaron E.;
Haughey, Norman J.;
Lublin, Fred D.;
Casaccia, Patrizia

Publication type:

Article

Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Published in:

Brain: A Journal of Neurology, 1999, v. 122, n. 5, p. 871, doi. 10.1093/brain/122.5.871

By:

Cutter, Gary R.;
Baier, Monika L.;
Rudick, Richard A.;
Cookfair, Diane L.;
Fischer, Jill S.;
Petkau, John;
Syndulko, Karl;
Weinshenker, Brian G.;
Antel, Jack P.;
Confavreux, Christian;
Ellison, George W.;
Lublin, Fred;
Miller, Aaron E.;
Rao, Stephen M.;
Reingold, Stephen;
Thompson, Alan;
Willoughby, Ernest

Publication type:

Article

Neurological Disorders of Pregnancy.

Published in:

Neurorehabilitation & Neural Repair, 1987, v. 1, n. 3, p. 147, doi. 10.1177/136140968700100310

By:

Miller, Aaron E.

Publication type:

Article

Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).

Published in:

2016

By:

Zivadinov, Robert;
Cookfair, Diane L.;
Krupp, Lauren;
Miller, Aaron E.;
Lava, Neil;
Coyle, Patricia K.;
Goodman, Andrew D.;
Jubelt, Burk;
Lenihan, Michael;
Herbert, Joseph;
Gottesman, Malcolm;
Snyder, David H.;
Apatoff, Brian R.;
Teter, Barbara E.;
Perel, Allan B.;
Munschauer, Frederick;
Weinstock-Guttman, Bianca

Publication type:

journal article

Sleep disturbance and memory dysfunction in early multiple sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2021, v. 8, n. 6, p. 1172, doi. 10.1002/acn3.51262

By:

Sumowski, James F.;
Horng, Sam;
Brandstadter, Rachel;
Krieger, Stephen;
Leavitt, Victoria M.;
Katz Sand, Ilana;
Fabian, Michelle;
Klineova, Sylvia;
Graney, Robin;
Riley, Claire S.;
Lublin, Fred D.;
Miller, Aaron E.;
Varga, Andrew W.

Publication type:

Article

Teriflunomide for the treatment of relapsing-remitting multiple sclerosis.

Published in:

Expert Review of Clinical Immunology, 2015, v. 11, n. 2, p. 181, doi. 10.1586/1744666X.2015.993611

By:

Miller, Aaron E

Publication type:

Article

Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience.

Published in:

Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 12, p. 381, doi. 10.1177/1756285617722500

By:

Miller, Aaron E.

Publication type:

Article

(DMT21) Glatiramer Acetate Depot (Extended Release) Phase 2a Study in Patients With Primary Progressive Multiple Sclerosis: Safety and Efficacy Snapshot.

Published in:

International Journal of MS Care, 2024, v. 26, p. 33

By:

Flechter, Shlomo;
Miller, Aaron E.;
Popper, Laura;
Almog, Ornit;
Kimelman, Nadav Bleich;
Rubnov, Shai;
Danon, Uri;
Marom, Ehud;
Milo, Ron;
Eilam, Anda;
Vaknin-Dembinsky, Adi;
Hellmann, Mark;
Shifrin, Alla;
Karni, Arnon

Publication type:

Article

(DMT19) The Efficacy of Glatiramer Acetate Depot in Patients With Relapsing Forms of Multiple Sclerosis: Subgroup Analyses of Phase 3 Study.

Published in:

International Journal of MS Care, 2024, v. 26, p. 31

By:

Miller, Aaron E.;
Wynn, Daniel;
Weinstock-Guttman, Bianca;
Reder, Anthony T.;
Kolb, Hadar;
Popper, Laura;
Danon, Uri;
Kimelman, Nadav Bleich;
Rubnov, Shai;
Marom, Ehud;
Ganapathi, Prasanna

Publication type:

Article

(DMT07) Patient-Reported Outcome Results From the Open-Label Period of Glatiramer Acetate Depot Phase 3 Study in Patients With Relapsing Forms of Multiple Sclerosis.

Published in:

International Journal of MS Care, 2024, v. 26, p. 27

By:

Miller, Aaron E.;
Ganapathi, Prasanna;
Popper, Laura;
Kolb, Hadar;
Kimelman, Nadav;
Rubnov, Shai;
Danon, Uri;
Marom, Ehud

Publication type:

Article

(DXT37) Effect of Teriflunomide on Brain Volume Loss in Patients with Relapsing Multiple Sclerosis of Differing Ages in TEMSO.

Published in:

International Journal of MS Care, 2020, v. 22, n. S2, p. 28

By:

Jiwon Oh;
Wuerfel, Jens;
Khatri, Bhupendra O.;
Miller, Aaron E.;
Inshasi, Jihad Said;
Saiz, Albert;
Lublin, Alex L.;
Poole, Elizabeth M.;
Sprenger, Till

Publication type:

Article

Sex-Dependent Alterations in the mRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration.

Published in:

Neurotoxicity Research, 2022, v. 40, n. 5, p. 1464, doi. 10.1007/s12640-022-00545-z

By:

Miller, Aaron E.;
Daiwile, Atul P.;
Cadet, Jean Lud

Publication type:

Article

Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 479, doi. 10.1177/13524585241233999

By:

Miller, Aaron E

Publication type:

Article

Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 11, p. 1719, doi. 10.1177/13524585221089534

By:

Sprenger, Till;
Kappos, Ludwig;
Sormani, Maria Pia;
Miller, Aaron E;
Poole, Elizabeth M;
Cavalier, Steven;
Wuerfel, Jens

Publication type:

Article

A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 817, doi. 10.1177/13524585211035333

By:

Cohen, Jeffrey A;
Cameron, Michelle H;
Goldman, Myla D;
Goodman, Andrew D;
Miller, Aaron E;
Rollins, Anne;
Llorens, Lily;
Patni, Rajiv;
Elfont, Robert;
Johnson, Reed

Publication type:

Article

Immunological studies in senile dementia of the alzheimer type: Evidence for enhanced suppressor cell activity.

Published in:

Annals of Neurology, 1981, v. 10, n. 6, p. 506, doi. 10.1002/ana.410100603

By:

Miller, Aaron E.;
Neighbour, P. Andrew;
Katzman, Robert;
Aronson, Miriam;
Lipkowitz, Rochelle

Publication type:

Article